| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.24B | — |
| R&D Expense | $44.0M | +117.4% |
| SG&A Expense | $36.0M | +161.8% |
| Operating Income | -$85.7M | -121.6% |
| Pre-tax Income | -$48.5M | +54.3% |
| Income Tax | $0 | — |
| Net Income | -$48.5M | +54.3% |
| EPS (Basic) | -$0.25 | +67.5% |
| EPS (Diluted) | -$0.25 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.4M | -88.9% |
| Short-term Investments | $311.4M | +152.3% |
| Accounts Receivable | $3.3M | +365.6% |
| Current Assets | $371.6M | -29.8% |
| Total Assets | $598.0M | -6.9% |
| Current Liabilities | $20.2M | +108.0% |
| Total Liabilities | $29.8M | -41.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.7M | -68.4% |
| Capital Expenditures | $9.3M | +20.0% |
| Investing Cash Flow | -$309.1M | -44.6% |
| Financing Cash Flow | $1.1M | -99.8% |
| Free Cash Flow | -$54.0M | -57.4% |
| +67.5% |
| Stockholders' Equity |
| $568.2M |
| -3.9% |